TuHURA Biosciences, Inc. (HURA)
1.63
+0.02
(+1.24%)
USD |
NASDAQ |
Nov 06, 16:00
1.66
+0.03
(+1.84%)
After-Hours: 04:46
TuHURA Biosciences Price to Book Value : 5.696 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 5.696 |
| November 05, 2026 | 5.627 |
| November 04, 2026 | 6.011 |
| November 03, 2026 | 5.784 |
| November 02, 2026 | 6.011 |
| October 30, 2026 | 6.745 |
| October 29, 2026 | 7.199 |
| October 28, 2026 | 6.955 |
| October 27, 2026 | 7.374 |
| October 26, 2026 | 7.129 |
| October 23, 2026 | 7.619 |
| October 22, 2026 | 7.024 |
| October 21, 2026 | 7.287 |
| October 20, 2026 | 6.151 |
| October 19, 2026 | 6.221 |
| October 16, 2026 | 6.151 |
| October 15, 2026 | 6.396 |
| October 14, 2026 | 6.151 |
| October 13, 2026 | 6.326 |
| October 12, 2026 | 6.640 |
| October 09, 2026 | 6.850 |
| October 08, 2026 | 6.745 |
| October 07, 2026 | 6.920 |
| October 06, 2026 | 6.815 |
| October 05, 2026 | 6.535 |
| Date | Value |
|---|---|
| October 02, 2026 | 6.675 |
| October 01, 2026 | 6.920 |
| September 30, 2026 | 7.339 |
| September 29, 2026 | 7.234 |
| September 28, 2026 | 7.304 |
| September 25, 2026 | 7.339 |
| September 24, 2026 | 7.339 |
| September 23, 2026 | 7.164 |
| September 22, 2026 | 7.444 |
| September 21, 2026 | 7.619 |
| September 18, 2026 | 7.339 |
| September 17, 2026 | 7.304 |
| September 16, 2026 | 7.094 |
| September 15, 2026 | 7.094 |
| September 14, 2026 | 7.164 |
| September 11, 2026 | 7.164 |
| September 10, 2026 | 7.094 |
| September 09, 2026 | 7.024 |
| September 08, 2026 | 7.409 |
| September 04, 2026 | 7.479 |
| September 03, 2026 | 7.339 |
| September 02, 2026 | 7.304 |
| September 01, 2026 | 7.094 |
| August 31, 2026 | 7.444 |
| August 28, 2026 | 7.374 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.644 |
| Alnylam Pharmaceuticals, Inc. | 5.793 |
| Anika Therapeutics, Inc. | 1.416 |
| Savara, Inc. | 6.906 |
| Vericel Corp. | 7.257 |
Price to Book Value Related Metrics
| Price | 1.63 |
| Earnings Yield | -32.72% |
| Market Cap | 103.80M |